Statistics

Total Visits

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)153

Select a period of time:

Number of views in the range

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)58

Views

Views
November 20254
December 20257
January 202610
February 20261
March 202613
April 202617
May 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States35
Brazil6
Venezuela3
United Kingdom3
Mexico2
Argentina2
France1
Guatemala1
Japan1
Morocco1
 

Top cities views

Views
San Jose10
Ashburn6
Amsterdam1
Atlanta1
Barra do Piraí1
Bauru1
Blackwood1
Boulay-Moselle1
Buffalo1
Caxias do Sul1